BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 1634099)

  • 1. [Epidermal growth factor receptor in human breast cancer: correlation with steroid receptors, tumor stage, grading and menopausal status].
    Speiser P; Sliutz G; Zeillinger R; Czerwenka K; Jakesz R; Knogler W; Kury F; Reiner A; Sevelda P; Schneeberger C
    Geburtshilfe Frauenheilkd; 1992 Jun; 52(6):355-9. PubMed ID: 1634099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGF-R and steroid receptors in breast cancer: a comparison with tumor grading, tumor size, lymph node involvement, and age.
    Zeillinger R; Kury F; Speiser P; Sliutz G; Czerwenka K; Kubista E
    Clin Biochem; 1993 Jun; 26(3):221-7. PubMed ID: 8392451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epithelial growth factor receptors (EGF-R) and DNA flow cytometry in addition to lymph node and hormone receptor status as prognostic factors in primary breast cancer].
    Costa SD; Kaufmann M; Fabbro D; Tokus M; Feichter G; Klinga K; Bastert G
    Geburtshilfe Frauenheilkd; 1989 Apr; 49(4):375-8. PubMed ID: 2544476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunohistochemical detection of EGF-receptors in breast cancers].
    Kopp A; von Laffert C; Jonat W
    Geburtshilfe Frauenheilkd; 1993 Jul; 53(7):461-6. PubMed ID: 8370486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
    Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical detection of epidermal growth factor receptor lacks prognostic significance for breast carcinoma.
    Göhring UJ; Ahr A; Scharl A; Weisner V; Neuhaus W; Crombach G; Holt JA
    J Soc Gynecol Investig; 1995; 2(4):653-9. PubMed ID: 9420872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Steroid hormone receptor status and other immunohistochemical prognostic markers in benign and malignant diseases of the breast].
    Nizze H; al-Thobhani AK; Terpe H
    Zentralbl Chir; 1998; 123 Suppl 5():14-8. PubMed ID: 10063564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistochemical detection of epidermal growth factor receptor (EGF-R) in paraffin sections of breast carcinoma tissue: correlation and clinical significance].
    Beckmann MW; Tutschek B; Göhring UJ; Engels K; Picard FK; Scharl A; Niederacher D; Schnürch HG
    Geburtshilfe Frauenheilkd; 1995 May; 55(5):258-65. PubMed ID: 7607382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptors for epidermal growth factor and steroid hormones in human breast cancer.
    Battaglia F; Polizzi G; Scambia G; Rossi S; Panici PB; Iacobelli S; Crucitti F; Mancuso S
    Oncology; 1988; 45(6):424-7. PubMed ID: 3186151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [C-erbB-2, EGF receptor, p53 and PCNA. The prognostic significance of recent tumor markers for lymph node negative breast cancer].
    Schönborn I; Minguillon C; Lichtenegger W; Zschiesche W; Spitzer E
    Geburtshilfe Frauenheilkd; 1995 Oct; 55(10):566-71. PubMed ID: 8543129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor in human breast cancer: correlation with steroid hormone receptors and axillary lymph node involvement.
    Battaglia F; Scambia G; Rossi S; Panici PB; Bellantone R; Polizzi G; Querzoli P; Negrini R; Iacobelli S; Crucitti F
    Eur J Cancer Clin Oncol; 1988 Nov; 24(11):1685-90. PubMed ID: 3061825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptors for epidermal growth factor and insulin-like growth factor I and their relation to steroid receptors in human breast cancer.
    Pekonen F; Partanen S; Mäkinen T; Rutanen EM
    Cancer Res; 1988 Mar; 48(5):1343-7. PubMed ID: 2963690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of epidermal growth factor receptor in breast cancer, from early stages to advanced disease.
    Nesković-Konstantinović Z; Nikolić-Vukosavljević D; Branković-Magić M; Kanjer K; Gavrilović D; Mitrović L; Borojević N; Vukotić D; Spuzić I
    J Exp Clin Cancer Res; 1999 Sep; 18(3):347-55. PubMed ID: 10606181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid receptor status and its clinicopathological correlation in post-menopausal breast cancer patients of Kumaon region of Uttarakhand.
    Shahi KS; Bhandari G; Singh A
    J Cancer Res Ther; 2011; 7(1):19-22. PubMed ID: 21546737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive.
    Van Calster B; Vanden Bempt I; Drijkoningen M; Pochet N; Cheng J; Van Huffel S; Hendrickx W; Decock J; Huang HJ; Leunen K; Amant F; Berteloot P; Paridaens R; Wildiers H; Van Limbergen E; Weltens C; Timmerman D; Van Gorp T; Smeets A; Van den Bogaert W; Vergote I; Christiaens MR; Neven P
    Breast Cancer Res Treat; 2009 Jan; 113(1):181-7. PubMed ID: 18264760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between epidermal growth factor receptor (EGF-R) and other predictors of prognosis in breast carcinomas. An immunohistochemical study.
    Martinazzi M; Crivelli F; Zampatti C; Martinazzi S
    Pathologica; 1993; 85(1100):637-44. PubMed ID: 8170712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidermal growth factor receptor (EGF-R) in human breast cancer--a marker of morphologic-functional differentiation].
    Scharl A; Göhring UJ; Vierbuchen M; Küsters B; Würz H
    Geburtshilfe Frauenheilkd; 1990 Nov; 50(11):877-82. PubMed ID: 2283014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of oestrogen receptor-beta in invasive breast tumours].
    Péter I; Számel I; Péley G
    Magy Onkol; 2004; 48(1):63-9. PubMed ID: 15105898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of immunohistochemical determination of receptors, tissue proteases, tumor suppressor proteins and proliferation markers as prognostic indicators in primary breast carcinoma].
    Göhring UJ; Scharl A; Ahr A
    Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):177-83. PubMed ID: 8682282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunohistochemical detection of pS2 protein in paraffin sections of breast carcinoma tissue. Comparison with results of an immunoradiometry assay].
    Ahr A; Scharl A; Göhring UJ; Crombach G; Stoffl M
    Pathologe; 1995 Jul; 16(4):278-84. PubMed ID: 7667210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.